Algenis


Leading company in the production and clinical development of bioactive molecules with medical use

“We started in 2002 with the objective of becoming in the leading company in the research of microalgae molecules”

TECHNOLOGIES WITH MULTIPLE CLINICAL APPLICATIONS

We work with sodium channels blocking molecules with the potential to treat multiple diseases.

WHAT WE DO

We research bioactive molecules produced by marine microalgae, which are a solution against different pathologies.

CLINICAL RESEARCH

Currently, Algenis is conducting Phase I clinical studies in front of the FDA.